FutureChem Co.Ltd - Asset Resilience Ratio

Latest as of March 2026: 24.16%

FutureChem Co.Ltd (220100) has an Asset Resilience Ratio of 24.16% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

₩16.84 Billion

≈ $11.42 Million USD Cash + Short-term Investments

Total Assets

₩69.72 Billion

≈ $47.25 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how FutureChem Co.Ltd's Asset Resilience Ratio has changed over time. Check how strategically is FutureChem Co.Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down FutureChem Co.Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see FutureChem Co.Ltd (220100) market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩16.84 Billion	24.16%
Total Liquid Assets	₩16.84 Billion	24.16%

Asset Resilience Insights

Good Liquidity Position: FutureChem Co.Ltd maintains a healthy 24.16% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

FutureChem Co.Ltd Industry Peers by Asset Resilience Ratio

Compare FutureChem Co.Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Beijing Sun Novo Pharmaceutical Research Co Ltd SHG:688621	Drug Manufacturers - Specialty & Generic	2.04%
Guizhou Xinbang Pharmaceutical Co Ltd SHE:002390	Drug Manufacturers - Specialty & Generic	0.01%
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	Drug Manufacturers - Specialty & Generic	7.85%
Jw Pharmac KO:001060	Drug Manufacturers - Specialty & Generic	3.65%
Kamada TA:KMDA	Drug Manufacturers - Specialty & Generic	0.00%
Samjin Pharm KO:005500	Drug Manufacturers - Specialty & Generic	0.25%

Annual Asset Resilience Ratio for FutureChem Co.Ltd (2016–2025)

The table below shows the annual Asset Resilience Ratio data for FutureChem Co.Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	29.78%	₩22.20 Billion ≈ $15.04 Million	₩74.53 Billion ≈ $50.51 Million	-7.06pp
2024-12-31	36.84%	₩27.42 Billion ≈ $18.58 Million	₩74.42 Billion ≈ $50.43 Million	+13.02pp
2023-12-31	23.82%	₩17.35 Billion ≈ $11.76 Million	₩72.83 Billion ≈ $49.36 Million	-18.50pp
2022-12-31	42.31%	₩37.54 Billion ≈ $25.44 Million	₩88.72 Billion ≈ $60.12 Million	+4.64pp
2021-12-31	37.67%	₩29.06 Billion ≈ $19.69 Million	₩77.14 Billion ≈ $52.27 Million	-14.26pp
2020-12-31	51.93%	₩42.82 Billion ≈ $29.02 Million	₩82.46 Billion ≈ $55.88 Million	+48.14pp
2019-12-31	3.79%	₩2.40 Billion ≈ $1.62 Million	₩63.21 Billion ≈ $42.84 Million	-55.97pp
2018-12-31	59.76%	₩38.28 Billion ≈ $25.94 Million	₩64.05 Billion ≈ $43.40 Million	+28.78pp
2017-12-31	30.98%	₩11.15 Billion ≈ $7.56 Million	₩36.00 Billion ≈ $24.40 Million	+12.86pp
2016-12-31	18.12%	₩6.00 Billion ≈ $4.07 Million	₩33.11 Billion ≈ $22.44 Million	--

pp = percentage points

About FutureChem Co.Ltd

KQ:220100 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$120.80 Million

₩178.26 Billion KRW

Market Cap Rank

#18420 Global

#791 in Korea

Share Price

₩7950.00

Change (1 day)

+4.33%

52-Week Range

₩6910.00 - ₩34200.00

All Time High

₩34200.00